QNCX
Quince Therapeutics, Inc.
$19.29
+2.04 (+11.83%)
At close · Jul 14
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of the uncertainty in securing additional funding and the insufficient amount of cash and cash equivalent resources as of the issuance of these unaudited condensed consolidated financial statements, management concluded that substantial doubt exists with respect to the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 11, 2026
Market Cap
$296.35M
Shares
16,300,740
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$19.29
Open$16.70
Day$16.23–19.98
52W$15.10–910.00
Avg vol 30d32K
Short int113K · 0.7% float · 4.8d
Short vol57%
Last earningsAug 13, 2024
DataJan 2020–Jul 2026
Filing10-Q · May 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.5 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−92%
below
Price vs 50-day avg
−7%
below
RSI (14)
52
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+3%
trailing
6-month return
−97%
trailing
YTD return
−97%
this year
Relative strength
−108%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $21 › 200d $237 — 200d above 50d
Institutional flow
Distributing
-28% holders QoQ · +17 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.69% of float · ▼ -94.4% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
48 holders — mid 3-yr range
Squeeze score
50
elevated · 0–100
Fundamentals
EPS growth
−28%
Y/Y
Free cash flow
$-41.8M
Balance sheet
$5.8M
net cash
Quant / Vol
risk profile
Volatility
356%
annualized · 1-yr
Max drawdown
−98%
past year
ATR
8.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−92%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $21 › 200d $237 — 200d above 50d
Institutional flow
Distributing
-28% holders QoQ · +17 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.69% of float · ▼ -94.4% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
48 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $15
Now $19 · 0%
52-wk high $910
vs 200-day avg -92%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
QNCX
this stock
Quince Therapeutics, Inc.
|
$296.35M | -97.1% | — | — | 0.7% |
|
ONC
BeOne Medicines Ltd.
|
$443.06B | +0.9% | +22179.2% | 901.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$120.89B | +5.1% | +46.2% | 28.3 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.79B | -14.9% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$53.96B | +2.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| QNCX | +10.2% | +3.3% | -97.2% | +6.1% | -97.1% |
| SPY | +0.6% | +1.4% | +11.0% | +0.7% | +10.3% |
| vs SPY | +9.7% | +1.9% | -108.1% | +5.4% | -107.4% |